MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release by MediPharm Labs Inc (CVE:LABS) (OTCMKTS:MLCPF) announcing that it has entered into a multi-year cannabis extraction agreement with TerrAscend Corp. (CNSX:TER) (OTCMKTS:TRSSF).
TerrAscend Corp. (CNSX:TER) (OTCMKTS:TRSSF) is focused on creating and delivering quality cannabis products and services that meet the evolving needs of patients and adult consumers. TerrAscend currently operates in the Canadian market and intends to expand into the United States.
TerrAscend Corp. (the “Company”) is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market. The Company provides support to patients and consumers through its wholly-owned subsidiaries, TerrAscend Canada Inc., a licensed cannabis producer under the Cannabis Act that provides medical cannabis to patients through its online medical marketplace Solace Health, and Solace Health Network Inc., a clinical support program and education platform led by healthcare professionals. The Company participates in the adult-use market in Canada through direct and indirect supply agreements in several provinces. The Company holds a partnership with leading researchers in Ascendant Labs, a cannabis biotechnology and licensing company committed to the continuous improvement of the cannabis plant, and is pursuing sophisticated pharmaceutical formulations with Solace Rx, a proposed Drug Preparation Premises facility that will deliver formulations to addr ess unmet medical needs where no commercial product is otherwise available.
465 COMPANY PROFILE VIEWS
- Health & Pharm Principal Industry
- Healthcare  Homepage